![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Signa S.a. De C.v. Toluca Mx, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Valsartan, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2011-231 - Rev 00
This Chemical Type CEP, issued on June 24, 2014, remains in force until June 24, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes